Document is current
Any future updates will be listed below
-
Authors
Coorens, Tim H. H. https://orcid.org/0000-0002-5826-3554
Collord, Grace https://orcid.org/0000-0003-1924-4411
Jung, Hyungchul
Wang, Yichen https://orcid.org/0000-0001-5122-7545
Moore, Luiza https://orcid.org/0000-0001-5315-516X
Hooks, Yvette
Mahbubani, Krishnaa https://orcid.org/0000-0002-1327-2334
Law, Simon Y. K.
Yan, Helen H. N. https://orcid.org/0000-0001-5693-8231
Yuen, Siu Tsan
Saeb-Parsy, Kourosh https://orcid.org/0000-0002-0633-3696
Campbell, Peter J. https://orcid.org/0000-0002-3921-0510
Martincorena, Iñigo https://orcid.org/0000-0003-1122-4416
Leung, Suet Yi https://orcid.org/0000-0001-8614-4619
Stratton, Michael R. https://orcid.org/0000-0001-6035-153X
- License Information
-
More Information
Article History
Received: 11 March 2024
Accepted: 28 January 2025
First Online: 19 March 2025
Competing interests
: I.M., P.J.C. and M.R.S. are cofounders, stockholders and consultants for Quotient Therapeutics Ltd. S.Y.L. has received research sponsorships from Pfizer, Merck and Servier. The other authors declare no competing interests.
